Search results
Author(s):
Rakesh Latchamsetty
Added:
3 years ago
Introduction
Premature ventricular complexes (PVCs) in the absence of underlying structural heart disease have long been viewed as benign. Early studies with small population sizes and limited cardiac testing suggested that long-term prognosis in patients with idiopathic PVCs is similar to those in patients without other cardiac disease, and treatment was consequently limited to provide…
View more
Author(s):
Kathy Glatter
Added:
3 years ago
Introduction
Strictly speaking, there are no arrhythmias that are specific to women. However, as with most diseases, the diagnosis of arrhythmias presents unique challenges when applied to women. Women have distinct symptoms, different etiologies and incidences of arrhythmias, and even differing outcomes compared with men.
This article will discuss both the benign and more malignant arrhythmias…
View more
Author(s):
Kathy Glatter
Added:
3 years ago
Introduction
Strictly speaking, there are no arrhythmias that are specific to women. However, as with most diseases, the diagnosis of arrhythmias presents unique challenges when applied to women. Women have distinct symptoms, different etiologies and incidences of arrhythmias, and even differing outcomes compared with men.
This article will discuss both the benign and more malignant arrhythmias…
View more
Author(s):
Sahar S Abdelmoneim
,
Sharon L Mulvagh
Added:
3 years ago
Several advances in the field of echocardiography have led to improvements in the accuracy of stress echocardiography (SE) and further strengthened its established diagnostic and prognostic role in patients with known or suspected coronary artery disease (CAD). 1,2 In addition to its role in CAD, SE can be used to assess the severity of valvular heart disease and for detection of occult pulmonary…
View more
Author(s):
Alexander Romanov
Added:
4 years ago
Dr Alexander Romanov (State Research Institute of Circulation Pathology) discusses the RAS trial that investigates radiofrequency (RF) ablation versus medical therapy for symptomatic frequent ventricular premature complexes as a first-line therapy in paediatric populations.
Filmed on site at EHRA 2019 by Radcliffe Cardiology
Questions:
1. What is aim of this study?
2. How was the ablation…
View more
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
The use of implantable devices to treat arrhythmias started with the implantable pacemaker back in the late 1950s. The risks and costs of implantation limited the indications for the procedure initially. A similar pattern was seen with the initial implantable cardioverter-defibrillators (ICDs) in the early 1980s. In the late 1990s, technology of both these devices focused on the management of…
View more
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
Abstract
The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter…
View more
Author(s):
Tasneem Z Naqvi
Added:
3 years ago
Congestive heart failure (CHF) is the number one hospital discharge diagnosis for older adults and the leading cause of hospital readmissions, reflecting poor quality of life for patients and increased healthcare resource use, and is the cause of 300,000 deaths annually.1 Cardiac resynchronization therapy (CRT) has become a new effective treatment modality in those with drug-resistant advanced…
View more
Author(s):
Pragnesh Parikh
,
KL Venkatachalam
Added:
3 years ago
Atrial fibrillation (AF) is the most common pathologic clinical arrhythmia lasting more than 30 seconds, and its incidence and prevalence continue to increase. It has been estimated that 5.9 % of patients aged >65 years suffer from AF.1 In the Rotterdam study, 17.8 % of patients over 85 had AF.2 The lifetime risk for developing AF in both men and women above age 40 is one in four.3 This…
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more